CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines

In 90% of pancreatic ductal adenocarcinoma cases, genetic alteration of the proto-oncogene Kras has occurred, leading to uncontrolled proliferation of cancerous cells. Targeting Kras has proven to be difficult and the battle against pancreatic cancer is ongoing. A promising approach to combat cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lentsch, Eva, Li, Lifei, Pfeffer, Susanne, Ekici, Arif B., Taher, Leila, Pilarsky, Christian, Grützmann, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888344/
https://www.ncbi.nlm.nih.gov/pubmed/31739488
http://dx.doi.org/10.3390/ijms20225706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888344/
https://www.ncbi.nlm.nih.gov/pubmed/31739488
http://dx.doi.org/10.3390/ijms20225706

Ejemplares similares